We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
139 hedge funds and large institutions have $310M invested in Anavex Life Sciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 30 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more call options, than puts
Call options by funds: $20.8M | Put options by funds: $9.48M
83% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 30
3.81% more ownership
Funds ownership: 29.08% → 32.89% (+3.8%)
7% less funds holding
Funds holding: 149 → 139 (-10)
19% less capital invested
Capital invested by funds: $383M → $310M (-$73.4M)
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
Holders
139
Holders Change
-10
Holders Change %
-6.71%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
55
Reduced
30
Closed
32
Calls
$20.8M
Puts
$9.48M
Net Calls
+$11.4M
Net Calls Change
+$7.34M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$21.4M |
| 2 |
Morgan Stanley
New York
|
+$4.78M |
| 3 |
D.E. Shaw & Co
New York
|
+$3.6M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$2.61M |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.59M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$4.98M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.24M |
| 3 |
Citigroup
New York
|
-$1.74M |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$1.04M |
| 5 |
Barclays
London,
United Kingdom
|
-$891K |
